{"id":"iodixanol-320-arm-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Contrast-induced nephropathy (acute kidney injury)"},{"rate":null,"effect":"Allergic reactions (mild to severe)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Thrombosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iodixanol contains iodine atoms that absorb X-rays, creating contrast between different tissue densities on radiographic images. As an iso-osmolar contrast medium (osmolality ~290 mOsm/kg, matching blood), it is designed to minimize osmotic stress on cells and reduce nephrotoxicity compared to hyperosmolar contrast agents. It is used intravenously during angiography, coronary interventions, and other vascular imaging procedures.","oneSentence":"Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:33:31.664Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Coronary angiography and percutaneous coronary intervention"},{"name":"Peripheral vascular angiography"},{"name":"Renal artery imaging"},{"name":"General vascular and cardiac imaging procedures"}]},"trialDetails":[{"nctId":"NCT00804531","phase":"PHASE4","title":"Intra-discal Steroid Injection for MODIC I Discopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-04","conditions":"Back Pain Lower Back Chronic","enrollment":137},{"nctId":"NCT01534975","phase":"NA","title":"Comparison of Contrast Agents During CT Angiography","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2012-01","conditions":"Contrast Enhancement on Cardiac CT","enrollment":513},{"nctId":"NCT02476526","phase":"PHASE4","title":"Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease","status":"COMPLETED","sponsor":"VA Greater Los Angeles Healthcare System","startDate":"2008-09","conditions":"Chronic Kidney Disease, Pulmonary Embolism, Renal Artery Stenosis","enrollment":50},{"nctId":"NCT00209417","phase":"PHASE4","title":"Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography","status":"TERMINATED","sponsor":"GE Healthcare","startDate":"2005-06","conditions":"Renal Insufficiency, Diabetes Mellitus","enrollment":656},{"nctId":"NCT01376089","phase":"PHASE4","title":"Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2011-05","conditions":"Patient Comfort and Safety","enrollment":304}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Visipaque"],"phase":"marketed","status":"active","brandName":"Iodixanol 320-Arm 1","genericName":"Iodixanol 320-Arm 1","companyName":"GE Healthcare","companyId":"ge-healthcare","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iodixanol is a non-ionic, iso-osmolar contrast medium that provides radiographic visualization of blood vessels and organs during diagnostic imaging procedures. Used for Coronary angiography and percutaneous coronary intervention, Peripheral vascular angiography, Renal artery imaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}